期刊文献+

沙利度胺联合复方氟米松软膏治疗结节性痒疹疗效观察 被引量:4

Efficacy Observation of Thalidomide Combined Flumetasone Ointment in the Treatment of Prurigo Nodularis
下载PDF
导出
摘要 目的观察沙利度胺联合复方氟米松软膏治疗结节性痒疹疗效。方法将87例结节性痒疹患者随机分为两组。治疗组45例,口服沙利度胺50mg,2次/d,症状改善后逐步减量50mg或25mg,1次/d维持,联合外用复方氟米松软膏,1次/d,共8周;对照组42例,口服左西替利嗪片5mg,1次/d,联合外用复方氟米松软膏1次/d,共8周。结果治疗组有效率为91.11%,对照组为69.05%,两组有效率差异有统计学意义(P<0.05),均无明显不良反应。结论沙利度胺联合复方氟米松软膏治疗结节性痒疹安全可靠。 Objective To observe the clinical efficacy of combination of thalidomide and flumetasone ointment in the treatment of prurigo nodularis. Methods Eighty-seven patients were randomly divided into two groups. 45 pa- tients in the treatment group were treated with thalidomide and flumetasone ointment for 8 weeks. Initial dose of thalido- mide is 50rag twice a day, and the dose is reduced to 50rag or 25rag once a day when symptoms are improved gradually. Flumetasone ointment is administrated once a day. Forty-two patients in the control group were treated with levoeetirizine and flumetasone ointment for 8 weeks. The dose of is levocetirizine 5mg once a day, and flumetasone ointment is admin- istrated once a day. Results After 8 weeks, the effective rates of treatment group was 91.11%, and the control group was 69.05 %. There was statistical significance between the two groups (P 〈 0. 05 ). Conclusion It was safe and relia- ble to treat prurigo nodularis with combination of thalidomide and flumetasone ointment.
出处 《中国医学文摘(皮肤科学)》 2014年第6期339-340,共2页 China Medical Abstracts(Dermatology)
关键词 沙利度胺 复方氟米松软膏 结节性痒疹 疗效观察 Thalidomide Flumetasone ointment Prurigo nodularis Efficacy observation
  • 相关文献

参考文献7

二级参考文献51

  • 1许惠娟.全反式维A酸胶囊与复方倍他米松软膏治疗结节性痒疹68例疗效比较[J].中华皮肤科杂志,2004,37(6):377-377. 被引量:10
  • 2耿铁军.局部注射治疗结节性痒疹[J].中国校医,2006,20(6):616-616. 被引量:3
  • 3De D, Dogra S, Kanwar AJ. Pmrigo nodularis in healed herpes zoster scar: an isotopic response. J Eur Acad Dermatol Venereol, 2007, 21 ( 5 ): 711-712.
  • 4Schneider G, Hockmann J, Stander S, et al. Psychological factors in prurigo nodularis in comparison with psoriasis vulgaris: results of a case-control study. Br J Dermatol, 2006, 154 (1): 61-66.
  • 5Funaki N, Ohno T, Dekio S, et al. Prurigo nodularis associated with advanced gastric cancer: report of a case. J Dermatol, 1996, 23( 10): 703-707.
  • 6Sonkoly E, Muller A, Lauerma AI, et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol, 2006, 117(2): 411-417.
  • 7Matthews S, Cockerell C. Prurigo nodularis in H1V-infected individuals, lnt J Dermatol, 1998, 37(6): 401-409.
  • 8Torchia D, Caproni M, Del Bianco E, et al. Linear IgA disease presenting as prurigo nodularis. Br J Dermatol, 2006, 155 (2): 479-480.
  • 9Freytes DM, Arroyo-Novoa CM, Figueroa-Ramos MI, et al. Skin disease in HIV-positive persons living in Puerto Rico. Adv Skin Wound Care, 2007, 20(3): 149-156.
  • 10Grillo M, Long R, Long D. Habit reversal training for the itch-scratch cycle associated with pruritic skin conditions. Der- matol Nurs, 2007, 19(3 ): 243-248.

共引文献45

同被引文献24

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部